Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

NCT05457465 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT05457465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05457465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
Lead sponsor
Mclean Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2023
Completion date
December 31, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder